loader from loading.io

New Study Results with Drs Kat Toups & Dale Bredesen

Evolving Past Alzheimer's

Release Date: 06/01/2021

Working with Trauma in Alzheimer's & Dementia show art Working with Trauma in Alzheimer's & Dementia

Evolving Past Alzheimer's

Trauma can be defined as any event that alters how we process, react to, and recall memories, by overwhelming the individual’s central nervous system. Additionally, trauma is defined as any event in which a person feels helpless and unsafe. It is not only an occurrence that happened in the past; instead, trauma is an event that leaves an imprint upon the body and the brain which persists to the present day.

info_outline
Why I'm excited about Aducanumab (Aduhelm)! show art Why I'm excited about Aducanumab (Aduhelm)!

Evolving Past Alzheimer's

Dr. Nate Bergman quickly summarizes the story up the FDA's recent "accelerated approval" of Biogen's - Aducanumab (brand named, Aduhelm). He ends off with surprise about why he is excited about the approval...and it's probably not what you think! A quick, but useful listen.

info_outline
Living well with Alzheimer's - Lisa's story of getting back to herself. show art Living well with Alzheimer's - Lisa's story of getting back to herself.

Evolving Past Alzheimer's

This episode is an important listen for anyone with doubts, reservations, or skepticism around a precision, functional medicine approach to the treatment of Alzheimer's disease.

info_outline
Does the new Alzheimer's drug Aducanumab mean the end of Alzheimer's? with Marwan Sabbagh, MD. show art Does the new Alzheimer's drug Aducanumab mean the end of Alzheimer's? with Marwan Sabbagh, MD.

Evolving Past Alzheimer's

In this episode, we hear the argument in favor of the new Alzheimer's drug, Aducanumab (Aduhelm).  Dr. Marwan Sabbagh is a clinical and research leader at the Cleveland Clinic's Lou Ruvo Center for Brain Health. He was a doctor that saw patients in one of the trials that led to the FDA's Accelerated (provisional) Approval. 

info_outline
People Getting Better- More Trial Results with Drs Ann Hathaway & Deborah Gordon show art People Getting Better- More Trial Results with Drs Ann Hathaway & Deborah Gordon

Evolving Past Alzheimer's

This week we will do almost a Part 2 from the last episode with Drs Dale Bredesen and Kat Toups.  In that episode, we featured recently released results data on MedArchive from a clinical trial in which 84% of 25 patients with early Alzheimer's Disease and Mild Cognitive Impairment improved with a Precision Medicine approach.  

info_outline
New Study Results with Drs Kat Toups & Dale Bredesen show art New Study Results with Drs Kat Toups & Dale Bredesen

Evolving Past Alzheimer's

Our guests today are Drs Kat Toups & Dale Bredesen.

info_outline
Being Patient - The Evolution of Data in Alzheimer's & Dementia with Deborah Kan show art Being Patient - The Evolution of Data in Alzheimer's & Dementia with Deborah Kan

Evolving Past Alzheimer's

Deborah Kan is a former executive producer with the Wall Street Journal. In 2017 she founded the website BeingPatient.com, a comprehensive website dedicated to Alzheimer's news, stories, and support.

info_outline
Pushing Back Against Dementia - Chrissy's Journey show art Pushing Back Against Dementia - Chrissy's Journey

Evolving Past Alzheimer's

We are witnessing a sea change in dementia. More people are being diagnosed, earlier and younger. And people are figuring out how to actually fight back against the disease and taking ownership of their condition.

info_outline
A Patient Story: The Heart-Brain Connection & Energy  show art A Patient Story: The Heart-Brain Connection & Energy

Evolving Past Alzheimer's

George suffered a major brain injury as a result of his heart stopping about 4 years ago.  Fortunately, he has successfully recovered from the brain injury and this is the story of how the Mullers did it!

info_outline
Taking Hormones After Menopause - New Data with Felice Gersh MD show art Taking Hormones After Menopause - New Data with Felice Gersh MD

Evolving Past Alzheimer's

We get many questions from listeners and people seeking Alzheimer’s prevention and early intervention about the risks and benefits of hormone therapies, such as estrogen and progesterone.

info_outline
 
More Episodes

Our guests today are Drs Kat Toups & Dale Bredesen.

Link to the study results just released online:

https://www.medrxiv.org/content/10.1101/2021.05.10.21256982v1.full.pdf

 

Important to note, this has not yet been peer-reviewed yet.

25 participants in this group, underwent a 9-month trial.

21 people improved, 1 person no real changes and 3 people got worse to some degree.

 

2:32 - what is MedArchive and have these study results been peer-reviewed yet? 

5:05 - the results of the study and what they learned about cognitive impairment 

10:23 - how they determined the cutoff for the participants in the study 

17:15 - lessons Dale brought into the study from his previous trial 

23:53 - how they proved that environmental factors were leading to cognitive decline 

31:03 - key attributes to people who are successful in improving during the study 

35:07 - main factors that lead to exposure to toxicity 

44:34 - the decision to study genetic factors of Alzheimer's and cognitive decline 

50:26 - responding to criticisms of the trial 

58:58 - plans for a follow-up trial